Last reviewed · How we verify
Prednisone 5 mg
Prednisone 5 mg is a Small molecule drug developed by Pfizer. It is currently FDA-approved. Also known as: Deltasone, Meticorten, Orasone, Prednicen-M.
At a glance
| Generic name | Prednisone 5 mg |
|---|---|
| Also known as | Deltasone, Meticorten, Orasone, Prednicen-M, Prednicot |
| Sponsor | Pfizer |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Short-term Steroid Therapy in Patients With P. Jirovecii Pneumonia Due to HIV / AIDS (NA)
- A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001) (PHASE3)
- Virotherapy and Natural History Study of KHSV-Associated Multricentric Castleman s Disease With Correlates of Disease Activity (PHASE2)
- Celecoxib Plus R-CHOP vs R-CHOP in Newly Diagnosed Advanced CD5+ DLBCL (PHASE2)
- Bortezomib, Combination Chemotherapy, and Rituximab as First-Line Therapy in Treating Patients With Stage III or Stage IV Follicular Non-Hodgkin's Lymphoma (PHASE2)
- A Phase I/II Study of PDS01ADC With Docetaxel and Abiraterone in Adults With Metastatic Castration Sensitive and PDS01ADC With Docetaxel in Castration Resistant Prostate Cancer (PHASE1, PHASE2)
- A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010) (PHASE3)
- A Study of Niraparib Combination Therapies for the Treatment of Metastatic Castration-Resistant Prostate Cancer (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Prednisone 5 mg CI brief — competitive landscape report
- Prednisone 5 mg updates RSS · CI watch RSS
- Pfizer portfolio CI
Frequently asked questions about Prednisone 5 mg
What is Prednisone 5 mg?
Prednisone 5 mg is a Small molecule drug developed by Pfizer.
Who makes Prednisone 5 mg?
Prednisone 5 mg is developed and marketed by Pfizer (see full Pfizer pipeline at /company/pfizer).
Is Prednisone 5 mg also known as anything else?
Prednisone 5 mg is also known as Deltasone, Meticorten, Orasone, Prednicen-M, Prednicot.
What development phase is Prednisone 5 mg in?
Prednisone 5 mg is FDA-approved (marketed).
Related
- Manufacturer: Pfizer — full pipeline
- Also known as: Deltasone, Meticorten, Orasone, Prednicen-M, Prednicot
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing